We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas.
- Authors
Bellafante, Daniele; Gioia, Stefania; Faccioli, Jessica; Riggio, Oliviero; Ridola, Lorenzo; Nardelli, Silvia
- Abstract
Hepatic encephalopathy (HE) is a common complication of advanced liver disease and acute liver failure. It is a condition that features several neuropsychiatric symptoms that affect mortality, morbidity and the quality of patients' and caregivers' lives. An HE diagnosis is generally an exclusion diagnosis. Once the patient is admitted to the hospital, clinical examination, blood tests and eventually neuroimaging should be performed with the aim of ruling out other causes of acute brain dysfunction. Moreover, HE is recognized using various precipitants that can potentially promote its onset, alone or in combination, and must be identified. Once the diagnostic process is complete, a correct treatment should be started. The anti-HE treatment is based on a combination of the correction of precipitants; non-absorbable antibiotics, such as rifaximin; and non-absorbable disaccharides. Once the patient is discharged from the hospital, specific anti-HE therapy should be maintained in order to prevent other HE episodes.
- Subjects
HEPATIC encephalopathy; LIVER failure; HOSPITAL admission &; discharge; LIVER diseases; RIFAXIMIN
- Publication
Journal of Clinical Medicine, 2024, Vol 13, Issue 1, p166
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm13010166